2 Studies found

Cancer Research

Study Of An Investigational Drug For Newly Diagnosed Chronic Myeloid Leukemia

Seeking men and women with Chronic Myeloid Leukemia diagnosed within the last 3 months for a study of the effectiveness of an investigational drug compared to a Tyrosine Kinase Inhibitor (TKI) drug.

Cancer Research

An Open Label Study Of Asciminib In Patients With Chronic Myeloid Leukemia In Chronic Phase

Seeking men and women 18 years of age and older who have chronic myeloid leukemia (CML) in chronic phase (CP) with and without the T315I mutation, to determine how well the treatment with asciminib works compared to previously used therapies.